CTRI/2012/03/002498已完成4 期
A phase IV multicentre study to confirm the safety and efficacy of Equine Antithymocyte globulin along with cyclosporine in patients with moderate to severe aplastic anaemia - ATG in AA
Bharat Serums and Vaccines Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Acquired aplastic anaemia
- •2.Age above 2 years
- •3.Hypocellular bone marrow- < 25%
- •4.With any severity of disease
排除标准
- •a.History of cancer
- •b.Creatinine > 2.5 times above the normal limit
- •c.HIV positive
- •d.Clonal disorder
- •e.Pregnancy
- •a.Participation in another investigational study within 30 days before the current study.
研究者
相似试验
进行中（未招募）
4 期
To assess how safe and effective Visanne (Dienogest) is in managing pelvic pain caused due to endometriosisCTRI/2022/04/041870Bayer Pharmaceuticals Pvt Ltd
进行中（未招募）
1 期
Study to assess the efficacy and safety of a basal insulin (Glargine 300) on glycemic control type 2 diabetic patients during hospitalization and at discharge.MedDRA version: 18.1Level: LLTClassification code 10049746Term: Insulin-requiring type II diabetes mellitusSystem Organ Class: 100000004861Type 2 DiabetesEUCTR2015-004715-20-ESSANOFI-AVENTIS, S.A.106
进行中（未招募）
4 期
To compare combination of study with marketed other combination of drug in patients having both anxiety and depression.CTRI/2022/11/047050Mankind Pharma Limited
尚未招募
4 期
A study to check safety and efficacy of Pregabalin Prolonged Release and Etoricoxib Tablet in patients with Chronic Low Back Pain Associated with Neuropathic ComponentCTRI/2022/05/042521Sun Pharma Laboratory Limited SP
已完成
4 期
A Post Marketing study of VELSEAL to control the bleeding from severely bleeding wounds due to accidents, trauma cases and deep arterial wounds.CTRI/2018/03/012373Datt Mediproducts Pvt Ltd101